Objective. Assess the workforce and workplace for rheumatology, and the investigative work of early career rheumatologists. Methods. Early career rheumatologists were defined as practicing physicians that joined the American College of Rheumatology (ACR) in 1991-2005, were 49 years of age or younger on joining, and resided in North America. This cohort participated in a Webbased survey distributed by ACR. A total of 247 survey instruments (21.2 % response) were used for this analysis. Survey questions were designed to obtain core insights about: the workforce, workplace, investigative activities, funding, and demographic profile. Results. Respondents from all workplaces---clinical, academic, federal, industrial---engaged in clinical care, teaching, administration, and research. The time devoted to these tasks was employer dependent, and workplaces shaped the scale and scope of research. Patient-oriented research was predominant across all workplaces. Disease-, population-, and translational-research was intermediate, and few respondents pursued basic-or prevention-oriented research in any workplace. Rheumatologists obtained extramural (21.3 %) and intramural (78.7 %) funds to pay portions of their salaries for time spent on research.
ground for producing the next generation of investigators needed to sustain medical progress. Third, a reward structure has evolved among clinical investigators leading to peer recognition, and the opportunity to obtain funds required for the production of a public good. In the case of rheumatologists, clinical investigation serves as the mechanism to advance clinical practice through the development of improved diagnostics, new treatments, and preventions that enhance the lives of the thousands of patients that suffer from a disorder occasioned by persistent pain and accumulated disability (1) .
The scope and scale of clinical research is unknown for any medical or surgical specialty beyond snapshots of the broad aims and expenditures of research programs sponsored by federal agencies or the pharmaceutical industry (2) (3) (4) . As a consequence, the workforce and workplace for clinical investigation is enigmatic and unexamined even after explicit warnings that an essential arm for advancing clinical practice has been disabled (5) (6) (7) (8) . The present study was designed to assess the workforce and workplace for rheumatology, and the extent and type of research prevailing among rheumatologists early in their careers. Our findings provide fresh insights about the workforce and the workplace for rheumatology, and justify interventions to address gaps in both the scope and scale of clinical research in arthritis and rheumatism.
MATERIALS AND METHODS
Survey participants. The ACR is the primary professional organization dedicated to advancing the practice of rheumatology in North America. An agreement was made with the ACR to distribute a Web-based questionnaire, produced by the authors, to member's email addresses. A letter of invitation from the ACR preceded respondent access to the survey instrument.
Rheumatologists, early in their careers, were identified based on five criteria: joined ACR between January 1, 1991 and December 31, 2005, earned an MD or equivalent degree, held an active license to practice medicine, resided in Canada or the US, and were 49 yr of age or younger on joining ACR. These criteria were adopted to assess physicians that complete fellowship training at a mean age of 34 yr, obtain support for their first research project grant at a mean age of 44.2 yr if they compete for federal grants/contracts, and function as principal investigator (PI) or co-principal investigator (Co-PI) for at least 5 yr (9) . to codify clinical investigation, and respect definitions adopted by others (6, 11, 12) . Respondent data, from both countries, were merged into a single data set since no significant differences (P > 0.50) were evident in any demographic measure (age, gender, ethnic background).
The self-identified ethnic backgrounds of rheumatologists from the US were compared with graduates of allopathic schools of medicine ( Table 1 ). The distribution of respondents from Asian and Hispanic/Latino backgrounds approached that of US graduates ( Table 1 ). The number of Black or African American rheumatologists, in contrast, was underrepresented in this survey sample by 6.5% while the number of Caucasians was overrepresented by a similar amount when compared with the cohort of individuals earning an MD degree in 1991 to 2005 (Table 1 ).
Workplace assessment. The time devoted to clinical service, teaching, research, and administration was estimated by asking respondents to specify the half-days/wk committed to these activities ( Table 2) . Clinical care was accomplished across all workplaces. Respondents employed in a solo or group practice, or health system, spent 7.9 half-days/wk on clinical service, a commitment exceeding that of other workplaces (P < 0.05). In contrast to providers, respondents employed by academic medical centers/teaching hospitals (AMCs), federal government, and pharmaceutical/biotech industry worked a respective 3.5, 2.3 and 1.5 half-days/wk on clinical service (Table 2) .
Rheumatologists from all workplaces participated in teaching medical students, residents, or fellows ( Table 2) .
Academic respondents devoted 1.3 half-days/wk to teaching whereas providers, federal employees, and those from industry spent 0.4, 0.6 and 0.5 half days/wk, respectively, which was significantly less (P < 0.01) than academics ( Table 2 ). Clinical care providers spent 1.4 half-days/wk conducting research.
Respondents from AMC's reported dedicating 4.0 half days/wk to research, while those in the federal and pharmaceutical/biotech sectors spent a respective 4.8 and 5.1 half days/wk ( Table 2) .
Administrative work, including committee responsibilities, involved 0.8 half days/wk among providers, 1.5 half days/wk in academic and federal workplaces, and 3.8 half days/wk in industry ( Table 2 ).
Scope and scale of research. The extent and type of research pursued by respondents was workplace dependent (Table 3) In the clinical care workplace, 59.3 % of providers pursued research albeit at levels below workplaces providing dedicated research time (Table 3) . Patient-, disease-, and populationoriented research involved a respective 36.4 %, 9.3 % and 6.8 % of providers. Providers pursued basic-, translational-, and prevention-oriented research, but the fraction of respondents was limited to 1.9 % to 3.1 % ( Table 3) . (Table 4 ). An average of 1.8
proposals was required per K08/23 award with a success rate of 41.1% per respondent or 22.2 % per application ( Table 4 ). Fewer training proposals were submitted to the VA in comparison to NIH, but with comparable success rates ( Table 4 ). The receipt of an NIH K08/23 award was a consequential marker of research project grants awarded to PI's and Co-PI's (P < 0.001).
Specifically, rheumatologists receiving a K-award were estimated to receive an average of 2.8 and 1.2 federal research project grants as respective PI's or Co-PI's. The association between the receipt of K-award and the subsequent receipt of a research project grant was independent of gender (P < 0.01). Women and men recipients of K-awards were just as likely to receive NIH R01 awards.
Respondents, from the US, produced 319 proposals as PI's or Co-PI's ( Table 4 ). Prospective PI's submitted an average of 2.8 research project proposals to NIH, and received 2.0 awards for a success rate of 51.1 % per respondent or 31.1% per proposal (Table 4 ). Fewer proposals were submitted to non-NIH HHS agencies and the VA, but respondent success exceeded (P < 0.05) that for NIH awards ( Table 4 ). The success of investigatorinitiated proposals considered by philanthropy, industry, and other funding sources was a respective 42 %, 43%, and 50% (Table   4 ). Proposals submitted by Co-PI's were funded on the same order (P > 0.15) as those of PI's ( Table 4 ).
Individual and institutional commitments to research.
Respondents were queried about their interest in pursuing investigative careers as medical students, residents, and Rheumatologists (72.4 %) viewed job uncertainty as a significant concern for clinical investigators relative to providers (P < 0.01). Respondents (75.6 %) perceived that the earnings of clinical investigators were less than those of providers (P < 0.01). This perception was tested by using a Tobit regression model specifying the natural logarithm of pretax annual earnings as a function of two key explanatory variables -years post fellowship and half-days/week devoted to research -as well as variables to control for gender, employment sector, and total work hours per week. The results indicate that pre-tax annual earnings increased linearly at 1.8
% per year of post-fellowship experience (Fig. 1A) . However, the earnings of rheumatologists devoting two or more half-days/wk to investigative work fell by 2.3 % per year for each half-day/wk spent on research (P < 0.01) relative to individuals spending one half-day/wk or less on investigative work (Fig.1B) .
Institutional support for early career academics was estimated by using the total dollar value of start-up packages provided for personnel, equipment, supplies, and other research expenses. Investment in the research programs of early career academic rheumatologists increased linearly with the number of half-days/wk devoted to research (Fig. 1C ). (Table 3) . While the survey did not distinguish among these possibilities, it seems likely that most provider research involved patient enrollment in protocols developed and funded by industrial or federal sponsors since provider research time was restricted to 15.3 % of their total professional effort ( Table 2 ). Certain rheumatologists in private practice, however, are known to participate in registries and other prospective cohort studies.
DISCUSSION
Rheumatologists employed in federal and pharmaceutical workplaces devoted more time to research than any other activity, and the distribution of investigative approaches was similar in both workplaces ( Table 3) (Table 4 ). Beyond this set of workforce constraints resides a host of limitations tied to an ailing and outmoded national infrastructure for sustaining clinical research (11, 19) . For instance, a disparity approaching 2:1 prevails for funding basic versus clinical research by federal agencies (20) (21) , and a recent report documents the difficulty of funding The present study is based on a limited number of survey participants. Responder participation in this survey, however, was consistent with that of other surveys accomplished by the ACR. Further, statistical comparisons of responders and nonresponders established that both cohorts were similar (P > 0.25) based on gender mix, age distribution, residency within states in the US, and country. Finally, the demographic profile of survey respondents conforms to data reported in the annual survey of graduate medical education for rheumatologists (18) , and data on the workforce for rheumatology (30) . Despite this evidence, the results should be viewed as an indicator rather than absolute measure of the workforce, workplace and the research accomplished by early career rheumatologists.
In conclusion, this study calls attention to multiple issues limiting advances in investigative rheumatology. The findings provide stakeholders---academic, federal, industrial, philanthropic, professional---with an evidence-based rationale to pursue multiple interventions for remodeling clinical research in rheumatology. The present results are not intended to detract from recent initiatives, championed by NIH, to improve the climate for clinical scholarship (31) (32) (33) . Instead, the findings compliment and extend the efforts made by NIH, and provide a rational framework to initiate a national dialog aimed at establishing a public and private infrastructure to support investigative rheumatology prudently and amply (34) . Only then will a bright future be assured for innovation and discovery in rheumatology, and benefit patients debilitated by musculoskeletal diseases.
AUTHORS CONTRIBUTIONS
C. Desjardins had access to all of the data in this study, and assumes responsibility for the integrity of the data and the accuracy of the data analysis. for the present survey of rheumatologists early in their careers. ‡ The number of American Indians and Alaskan Natives was not determined in this study, but are listed here to coincide with the demographic profiles of graduates from allopathic schools of medicine in the US (14) . § The fraction of individuals that self identified as "other" may include rheumatologists from ethnicities (American Indian, Alaskan Native, Hawaiian Native, Pacific Islander) that were unlisted in the survey instrument for this study, or it may consist of individuals whose ethnicity is unknown or undisclosed. Respondents were asked to specify the half days/wk devoted to the indicated activities during the 12 mo the preceded the survey based on the time they negotiated with their supervisors. The results provide an estimate of the time/effort reported for a putative 40 hr workweek since respondents were advised to exclude "off-the-clock" commitments for activities accomplished Institutional investments were based on the mean value of start-up packages (total institutional dollars [corrected to constant dollars] for personnel, equipment, supplies, and other research expenses) provided to early career rheumatologists employed at AMC's.
